دورية أكاديمية
A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma
| العنوان: | A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma |
|---|---|
| المؤلفون: | Hida, Toyoaki, Velcheti, Vamsidhar, Reckamp, Karen L., Nokihara, Hiroshi, Sachdev, Pallavi, Kubota, Tomoki, Nakada, Takuya, Dutcus, Corina E., Ren, Min, Tamura, Tomohide |
| المساهمون: | Eisai Inc., Woodcliff Lake, NJ, USA, Merck & Co., Inc., Kenilworth, NJ, USA |
| المصدر: | Lung Cancer ; volume 138, page 124-130 ; ISSN 0169-5002 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2019 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Pulmonary and Respiratory Medicine, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.lungcan.2019.09.011 |
| الإتاحة: | https://doi.org/10.1016/j.lungcan.2019.09.011Test https://api.elsevier.com/content/article/PII:S0169500219306555?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0169500219306555?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.E806A064 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.lungcan.2019.09.011 |
|---|